Progesterone therapy shows mixed results for neurodevelopment in infants with heart defects

FHS
June 3, 2024
1:47 am

A randomized clinical trial published in JAMA Network Open found no significant overall benefit of maternal progesterone therapy on neurodevelopmental outcomes in infants with congenital heart defects, but observed improvements in female children and specific heart conditions.

Vittoria’s CAR-T therapy secures clinical approval amid FDA scrutiny on sector – Pharmaceutical Technology

Share this article The FDA has an ongoing investigation for CAR-T cell immunotherapy safety. Credit: Tada Images/Shutterstock.com Vittoria Biotherapeutics will begin in-human studies of its

December 8, 2023

The Role of Qualified Medical Interpreters in Achieving Section 1557 Healthcare Compliance

Carla Fogaren R.N., Certified ADA Coordinator at AMN Language Services For the last decade, Section 1557 has been at the center of many changes and

October 11, 2023

Usefulness Questioned for Transplant Center Report Cards

Public report cards for heart transplant centers are under fire for not being meaningful — potentially even misrepresentative of care quality — as a given

April 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.